Hjem › Kronisk lymfatisk leukemi › Colorado › Denver
Kliniske studier for Kronisk lymfatisk leukemi i Denver, CO
9 studier for Kronisk lymfatisk leukemi søker deltakere på steder i og rundt Denver (innen ca. 30 miles). Åpne et studie for å se hvem som kan delta og hvordan du kontakter studieteamet.
Offisiell studietekst (engelsk)
Rekrutterer til et studie her? Få det fremtredende øverst på siden – $99 i 30 dager →
Testing the Addition of Anti-Cancer Drug Sonrotoclax, to the Standard Treatment Zanubrutinib, for Previously Untreated CLL/SLL
RekruttererFase 3
- Kaiser Permanente-Franklin, Denver
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
RekruttererObservasjonsstudieFrivillige helsepersonell ønskes velkommen
- AdventHealth Porter, Denver
A Study of Nemtabrutinib (MK-1026) Versus Comparator (Investigator's Choice of Ibrutinib or Acalabrutinib) in First Line (1L) Chronic Lymphocytic Leukemia (CLL)/ Small Lymphocytic Lymphoma (SLL) (MK-1026-011/BELLWAVE-011)
RekruttererFase 3
- Saint Joseph Hospital ( Site 0026), Denver
Single-arm Study of IgPro20 in Adults With Secondary Immune Deficiencies Due to Hematologic Malignancies Treated With B-cell Targeting Chimeric Antigen Receptor T-cell and T-cell Redirecting Therapies
RekruttererFase 3
- CBCI, Colorado Blood Cancer Institute, Denver
A Study of NX-5948 in Adults With CLL/SLL Previously Treated With a Bruton's Tyrosine Kinase Inhibitor and a B-cell Lymphoma-2 Inhibitor (DAYBreak CLL-201)
RekruttererFase 2
- Colorado Blood Institute, Denver
Gene Therapy for CD19-Positive Hematologic Malignancies (SENTRY-CD19)
RekruttererFase 1/2
- Colorado Blood Cancer Institute, Denver
A Study of NX-5948 in Adults With Relapsed/Refractory B-cell Malignancies
RekruttererFase 1
- Colorado Blood Cancer Institute, Denver
A Study of NX-2127 in Adults With Relapsed/Refractory B-cell Malignancies
RekruttererFase 1
- Sarah Cannon Research Institute at Colorado Blood Cancer Institute, Denver
A Study of AC676 for the Treatment of Relapsed/Refractory B-Cell Malignancies
RekruttererFase 1
- Colorado Blood Cancer Institute, Denver
Kronisk lymfatisk leukemi-studier i andre byer
- Boston, MA31 studier
- Columbus, OH28 studier
- Durham, NC27 studier
- Washington, DC22 studier
- Seattle, WA20 studier
- Rochester, MN19 studier
- New York City, NY18 studier
- Houston, TX17 studier
- Baldwin Park, CA16 studier
- Milwaukee, WI15 studier
- Chicago, IL14 studier
- Cincinnati, OH14 studier
Andre studier i Denver
- Metastatisk kreft29 studier
- Brystkreft28 studier
- Multipelt myelom27 studier
- Ikke-småcellet lungekreft27 studier
- Kolorektal kreft23 studier
- Prostatakreft19 studier
- Melanom19 studier
- Kreft (alle typer)18 studier
- Eggstokkreft16 studier
- Lungekreft16 studier
- Endometriekreft15 studier
- Non-Hodgkins lymfom14 studier
Fra ClinicalTrials.gov, data hentet 5. okt. 2026. Hver studie setter sine egne kvalifikasjonskrav; studieteamet avgjør hvem som kan delta.